In the BioHarmony Drug Report Database

"Preview" Icon

Voclosporin

Lupkynis, Ikervis, Verkazia (voclosporin) is a protein pharmaceutical. Voclosporin was first approved as Lupkynis on 2015-03-19. It is used to treat lupus nephritis in the USA. It has been approved in Europe to treat conjunctivitis, corneal diseases, and keratitis. The pharmaceutical is active against peptidyl-prolyl cis-trans isomerase A. Lupkynis’s patent is valid until 2037-12-07 (FDA).

 

Trade Name

 

Ikervis, Verkazia
 

Common Name

 

voclosporin
 

ChEMBL ID

 

CHEMBL2218919
 

Indication

 

conjunctivitis, corneal diseases, keratitis, lupus nephritis
 

Drug Class

 

Cyclosporine derivatives

Image (chem structure or protein)

Voclosporin structure rendering